Reduced BNT162b2 Messenger RNA Vaccine Response in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Naive Nursing Home Residents.
Reduced BNT162b2 Messenger RNA Vaccine Response in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Naive Nursing Home Residents.
复制标题
DOI:
10.1093/cid/ciab447
复制
发表时间:
2021-12-06
期刊:
影响因子:
--
通讯作者:
King CL
中科院分区:
文献类型:
--
作者:
Canaday DH;Carias L;Oyebanji OA;Keresztesy D;Wilk D;Payne M;Aung H;St Denis K;Lam EC;Rowley CF;Berry SD;Cameron CM;Cameron MJ;Wilson B;Balazs AB;Gravenstein S;King CL
After BNT162b2 messenger RNA vaccination, antibody levels to spike, receptor-binding domain, and virus neutralization were examined in 149 nursing home residents and 110 healthcare worker controls. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–naive nursing home residents’ median post–second vaccine dose antibody neutralization titers are one-quarter that of SARS-CoV-2–naive healthcare workers.
登录
查看更多内容
DOI:
10.1056/nejmoa2034577
发表时间:
2020-12-31
期刊:
The New England journal of medicine
影响因子:
--
作者:
Polack FP;Thomas SJ;Kitchin N;Absalon J;Gurtman A;Lockhart S;Perez JL;Pérez Marc G;Moreira ED;Zerbini C;Bailey R;Swanson KA;Roychoudhury S;Koury K;Li P;Kalina WV;Cooper D;Frenck RW Jr;Hammitt LL;Türeci Ö;Nell H;Schaefer A;Ünal S;Tresnan DB;Mather S;Dormitzer PR;Şahin U;Jansen KU;Gruber WC;C4591001 Clinical Trial Group
通讯作者:
C4591001 Clinical Trial Group
影响因子:
6.3
作者:
Mor, Vincent;Gutman, Roee;Gravenstein, Stefan A.
通讯作者:
Gravenstein, Stefan A.
DOI:
10.15585/mmwr.mm7017e2
发表时间:
2021-04-30
期刊:
MMWR. Morbidity and mortality weekly report
影响因子:
--
作者:
Cavanaugh AM;Fortier S;Lewis P;Arora V;Johnson M;George K;Tobias J;Lunn S;Miller T;Thoroughman D;Spicer KB
通讯作者:
Spicer KB
影响因子:
64.5
作者:
Garcia-Beltran WF;Lam EC;St Denis K;Nitido AD;Garcia ZH;Hauser BM;Feldman J;Pavlovic MN;Gregory DJ;Poznansky MC;Sigal A;Schmidt AG;Iafrate AJ;Naranbhai V;Balazs AB
通讯作者:
Balazs AB
影响因子:
64.5
作者:
Garcia-Beltran WF;Lam EC;Astudillo MG;Yang D;Miller TE;Feldman J;Hauser BM;Caradonna TM;Clayton KL;Nitido AD;Murali MR;Alter G;Charles RC;Dighe A;Branda JA;Lennerz JK;Lingwood D;Schmidt AG;Iafrate AJ;Balazs AB
通讯作者:
Balazs AB